ADPD 2017 – The 13th International Conference on Alzheimers & Parkinsons Diseases

Innoprot will be present in the AD/PD 2017, the 13th International Conference on Alzheimer’s / Parkinson’s Diseases, which will take place in Viena, Austria from 29th, March to 2nd, April, 2017. AD/PDTM 2017, the 13th​ International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, will build on the well-earned reputation of previous AD/PDTM​…

Myocardial fibrosis: biomedical research from bench to bedside

Myocardial fibrosis refers to a variety of quantitative and qualitative changes in the interstitial myocardial collagen network that occur in response to cardiac ischaemic insults, systemic diseases, drugs, or any other harmful stimulus affecting the circulatory system or the heart itself. Myocardial fibrosis alters the architecture of the myocardium, facilitating the development of cardiac dysfunction,…

Mitochondria in the context of Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1–2% of the population over the age of 65. Rigidity, bradikynesia, postural instability and tremor are the principal clinical characteristics of this disease, caused by the progressive loss and degeneration of dopaminergic neurons in the Substantia nigra pars compacta (SNpc). Tremor and motor impairment…

SLAS 2017 International Conference & Exhibition

Innoprot will be present in the SLAS 2017 International Conference & Exhibition in Washington on February 4th to 8th, 2.017. SLAS2017 is the annual International Conference and Exhibition from SLAS, the Society of Laboratory Automation and Screening. Through a unique combination of education, access to innovative technologies and intelligent peer networking, SLAS2017 delivers unmatched value…